Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rubin

Showing results (941-950 of 952) with videos related to

Pageof 96
Sort By:
Neuro-Oncology|May 10, 2018
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine gliomaNalin Gupta, Liliana C Goumnerova, Peter Manley, et al.
Cell Reports. Medicine|August 4, 2020
Pattern of Relapse and Treatment Response in WNT-Activated MedulloblastomaLiana Nobre, Michal Zapotocky, Sara Khan, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Nature|October 31, 2019
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastomaHiromichi Suzuki, Sachin A Kumar, Shimin Shuai, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Nature Communications|March 20, 2021
The transcriptional landscape of Shh medulloblastomaPatryk Skowron, Hamza Farooq, Florence M G Cavalli, et al.
Cancer Cell|June 14, 2017
Intertumoral Heterogeneity within Medulloblastoma SubgroupsFlorence M G Cavalli, Marc Remke, Ladislav Rampasek, et al.
The Lancet. Oncology|March 16, 2016
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M Thompson, Thomas Hielscher, Eric Bouffet, et al.
Pageof 96

Showing results (941-950 of 952) with videos related to

Sort By:
Pageof 96
Neuro-Oncology|May 10, 2018
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine gliomaNalin Gupta, Liliana C Goumnerova, Peter Manley, et al.
Cell Reports. Medicine|August 4, 2020
Pattern of Relapse and Treatment Response in WNT-Activated MedulloblastomaLiana Nobre, Michal Zapotocky, Sara Khan, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Nature|October 31, 2019
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastomaHiromichi Suzuki, Sachin A Kumar, Shimin Shuai, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Nature Communications|March 20, 2021
The transcriptional landscape of Shh medulloblastomaPatryk Skowron, Hamza Farooq, Florence M G Cavalli, et al.
Cancer Cell|June 14, 2017
Intertumoral Heterogeneity within Medulloblastoma SubgroupsFlorence M G Cavalli, Marc Remke, Ladislav Rampasek, et al.
The Lancet. Oncology|March 16, 2016
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M Thompson, Thomas Hielscher, Eric Bouffet, et al.
Pageof 96